Apomorfin PharmSwed 5 mg/ml infusjonsvæske

DRUG2 trials

Sponsors

Rigshospitalet

Conditions

Coma and other disorders of consciousness due to acute traumatic and non-traumatic brain injury

Phase 1

Boosting recovery through excitation of arousal and awareness in comatose patients: The BREA2KTHROUGH trial

WithdrawnCTIS2023-503617-30-01

RigshospitaletComa and other disorders of consciousness due to acute traumatic and non-traumatic brain injury

Target: 384Updated: 2023-11-20

Boosting recovery through excitation of arousal and awareness in comatose patients: Dose finding study (BREA2KTHROUGH DOSEFINDER)

RecruitingCTIS2023-503617-30-02

RigshospitaletComa and other disorders of consciousness due to acute traumatic and non-traumatic brain injury

Start: 2025-02-26Target: 384Updated: 2025-02-27